them.11-14 However, the comparatively few reports available
do reveal that oligomers derived from â2 amino acids produce
important and unusual structural motifs.15,16 Given this, and
Seebach’s work on fluorinated â3 amino acids, we now report
the first synthesis of R-fluorinated â2 amino acids for use in
defining the conformation of â-peptides containing them.17
Our methodology has been used to prepare 13a and 13b in
high enantiomeric excess, with 13a being converted to the
N-protected free acids 14a and 15a for use in peptide
synthesis.
Scheme 1. Establishing a Fluorinated Chiral Center
The incorporation of fluorine at the 2 position of â2 amino
acids provided a significant synthetic challenge. Direct
fluorination of â2 amino acids was problematic due to the
steric constraints involved in fluorinating an already crowded
tertiary substituted C-2 center. Consequently, it was decided
that fluorination of suitable 3-substituted propanoic acids
(where the 3-substituent becomes the side chain of the amino
acid), followed by introduction of a CH2NH2 group at the
2-position, would be the best approach. 3-Phenylpropanoic
acid 3a and 3-cyclohexylpropanoic acid 3b were selected
as starting materials for the development of this methodology
to prepare â2 amino acids with both “natural” (phenyl) and
“unnatural” (CH2-cyclohexyl) side chains (Schemes 1 and
2) and to access important examples for use in defining
â-peptide structure.17
The phenyl 3-substituted propanoic acid 3a (Scheme 1)
was converted to the corresponding acid chloride, and this
was reacted with the anion of (4S)-4-benzyl-2-oxazolidinone
to give oxazolidinone 4a in high yield. Subsequent fluorina-
tion by reaction with LDA and N-fluorobenzenesulfonimide
approach was necessary. To this end, alkylation of the sample
of 5a with TiCl4, Pr2Et, and benzyl chloromethyl ether as
the alkylating agent gave 7a in 70% yield and >95% de (as
determined by 1H and 19F NMR), where the benzyl-protected
hydroxylmethyl group is suitable for subsequent conversion
into the desired amine functionality (Scheme 2).
i
1
(NFBS) gave 5a in >90% de (determined by H and 19F
NMR) and in a yield of 79%. Separation of 5a from the
small amount of diastereomer 6a was not necessary given
the next step involved formation and alkylation of a prochiral
enolate intermediate.
Scheme 2. Synthesis of R-Fluorinated â2-Amino Acids
The direct addition of a CH2NHZ group to nonfluorinated
analogues of 5a has been reported using MeOCH2NHZ as
an alkylating reagent.14 However, this approach was unsuc-
cessful in our system, perhaps due to deactivation of the
intermediate enolate by the electronegative fluorine atom.
In support, other alkylating reagents including CH3I and CH3-
OCH2I were also unreactive toward the anion derived from
5, a result consistent with literature reports.18 Hence, a new
(9) Seebach, D.; Beck, A. K.; Bierbaum, D. J. Chem. BiodiVers. 2004,
1, 1111.
(10) Cheng, R. P.; Gellman, S. H.; DeGrado, W. F. Chem. ReV. 2001,
101, 3219.
(11) Moumne, R.; Lelais, G.; Seebach, D. Biopolymers 2004, 76, 206.
(12) Chi, Y. G.; Denise, B.; Guitot, K.; Rudler, H.; Lavielle, S.; Karoyan.
P. Eur. J. Org. Chem. 2007, 12, 1912.
(13) Gellman, S. H. J. Am. Chem. Soc. 2006, 128, 6804.
(14) Seebach, D.; Schaeffer, L.; Gessier, F.; Bindscha¨dler, P.; Ja¨ger, C.;
Josien, D.; Lelais, G.; Kopp, S.; Mahajan, Y. R.; Micuch, P.; Sebesta, R.;
Schweizer, B. W. HelV. Chim. Acta 2003, 86, 1852.
(15) Gessier, F.; Noti, C.; Rueping, M.; Seebach, D. HelV. Chim. Acta
2003, 86, 1862.
(16) Takeuchi, Y.; Nabetani, M.; Takagi, K.; Hagi, T.; Koizumi, T. J.
Chem. Soc., Perkin Trans. 1 1991, 49.
(17) Mathad, R. I.; Jaun, B.; Flo¨gel, O.; Lo¨weneck, M.; Gardiner, J.;
Seebach, D.; Graichen, F. H. M; Edmonds, M. K.; Abell, A.D. HelV. Chim.
Acta 2007, 90, 2251.
(18) Less, S. L.; Handa, S.; Millburn, K.; Leadlay, P. F.; Dutton, C. J.;
Staunton, J. Tetrahedron Lett. 1996, 37, 3515.
886
Org. Lett., Vol. 10, No. 5, 2008